Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.470
+0.090 (3.78%)
May 21, 2026, 12:27 PM EDT - Market open
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $313.88 million as of May 21, 2026. Its market cap has increased by 263.14% in one year.
Market Cap
313.88M
Enterprise Value
235.45M
1-Year Change
263.14%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $313.88M, an increase of 168.20%. That is a compound annual growth rate of 21.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 302.45M | 22.80% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 315.20M |
| Immuneering | 315.08M |
| Lineage Cell Therapeutics | 309.13M |
| Abeona Therapeutics | 306.06M |
| DiaMedica Therapeutics | 306.06M |
| Bicycle Therapeutics | 303.92M |
| Palisade Bio | 303.04M |
| Niagen Bioscience | 295.30M |